1,410
Participants
Start Date
February 28, 2007
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2016
Control group
Informing patient that fracture probably of fragility origin and suggesting to consult primary care practitioner. After 8 months, if not treated, Intensive intervention will be offered
Minimal Intervention
Multiple layers of intervention will be added: results of the basic blood investigation for osteoporosis will be transmitted to the family physician with a personal letter explaining the importance of seeing the patient rapidly and indicating the urgency of initiating a treatment and indicating detailed instructions of treatment. The patient will be called at 4, 8, 12,16 and 24 months to monitor drug adherence, correct inadequate intake, and try to improve adherence. If the patient is not taking an adequate treatment at 4, 8 or 12 months, a letter will be sent again to the family physician asking to treat the patient according to recommendations.
Intensive Intervention
"INTENSIVE INTERVENTION GROUP: 1/2 of patients, randomly selected results of the basic blood investigation for osteoporosis will be transmitted to the family physician with a personal letter explaining the importance of seeing the patient rapidly and indicating the urgency of initiating a treatment and indicating detailed instructions of treatment. The patient will be called at 4, 8, 12,16 and 24 months to monitor drug adherence, correct inadequate intake, and try to improve adherence. If the patient is not taking an adequate treatment at 4, 8 or 12 months, a letter will be sent again to the family physician asking to treat the patient according to recommendations.~Sequential serum will be stored frozen in order to measure levels of blood markers of bone metabolism (at a later date)"
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Collaborators (4)
Merck Sharp & Dohme LLC
INDUSTRY
Procter and Gamble
INDUSTRY
Sanofi
INDUSTRY
Novartis
INDUSTRY
Amgen
INDUSTRY
Eli Lilly and Company
INDUSTRY
Servier
INDUSTRY
Warner Chilcott
INDUSTRY
Université de Sherbrooke
OTHER